Latest News about DEA
Recent news which mentions DEA
Donald Trump And Viktor Bout Seem To Have A Few Things In Common Despite The Former Pres' Protests
December 12, 2022
Tickers
DEA
From Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
From Benzinga
12 Top Stocks to Buy in December
December 03, 2022
From Motley Fool
DEA Legalizes Cocaine Derivative As Diagnostic Aid For Parkinson's, Ignoring Cannabis Experts Seeking Same
November 23, 2022
Tickers
DEA
From Benzinga
Exclusive: BioHarvest Partners With DEA-Licensed Cannabis Grower To Supply Marijuana Products To Research Institutions
November 16, 2022
From Benzinga
3 Safe Dividend Stocks to Beat Inflation
November 10, 2022
From Motley Fool
4 Analysts Have This to Say About Easterly Government Props
November 03, 2022
Tickers
DEA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
From Benzinga
3 Top Dividend Stocks to Buy and Hold in 2023
October 25, 2022
From Motley Fool
3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
October 22, 2022
From Motley Fool
3 Attractive REITs With A Dividend Yield Over 6%
October 13, 2022
From Benzinga
3 Ridiculously Cheap High-Yield Dividend Stocks
October 12, 2022
From Motley Fool
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
October 04, 2022
From Benzinga
DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
September 29, 2022
Tickers
DEA
From Benzinga
Congressional Psychedelics Talks: Comments By Officials In Favor, Including Rep. Blumenauer And AOC
September 22, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Easterly Government Props
September 14, 2022
Tickers
DEA
From Benzinga
3 High-Yield Dividend Stocks to Buy in September Without Any Hesitation
September 03, 2022
From Motley Fool
Fetterman Calls On Biden To Decriminalize Cannabis, But White House Defers To States
August 30, 2022
Tickers
DEA
From Benzinga
From MarketWatch
DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
August 23, 2022
Tickers
DEA
From Benzinga
CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
August 18, 2022
From Benzinga
Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
August 17, 2022
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
From Benzinga
3 Dividend Stocks to Buy Right Now Without Any Hesitation
August 14, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.